Holes in the Swiss Cheese Model

Similar documents
A. Ketorolac*** B. Naproxen C. Ibuprofen D. Celecoxib

US Health Statistics: Americans Most Over-Prescribed Country in the World

Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia

Nonsteroidal. Drugs (NSAIDs) Anti-Inflammatory. North American Spine Society Public Education Series

Peptic Ulcer. Anatomy The stomach is a hollow organ. It is located in the upper abdomen, under the ribs.

Treatment with Apixaban

Articles Presented. Journal Presentation. Dr Albert Lo. Dr Albert Lo

Treatment with Rivaroxaban

Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting

Medication error is the most common

Over the Counter Drugs (OTCs): Considerations for Physical Therapy Practice in Canada

Truth or Consequences, Best Medication List Practices to Deliver Best Care. Leaning & Action Network Session

Inhibit terminal acid secretion from parietal cells by blocking H + /K + - ATPase pump

Medication Guide Plavix (PLAV-iks) (clopidogrel bisulfate) tablets

Conflict of Interest Disclosure

How Can We Get the Best Medication History?

Gloucestershire Hospitals

Person Centered Care: Walk the Talk

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

Practical experiences of risk minimisation

Daily aspirin therapy: Understand the benefits and risks

Medication Coordination and Coverage in Hospice

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Stowe School Medications Policy

There is a risk of renal impairment in dehydrated children and adolescents.

Introduction. Background to this event. Raising awareness 09/11/2015

Psoriasis and Psoriatic Arthritis Alliance

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

medicineupdate Tramadol for pain Asking the right questions about new medicines Page Section 1: What tramadol is 1 Section 2: What tramadol is for 1

What is Helicobacter pylori? hat problems can H. pylori cause? Does H. pylori cause cancer? ight H. pylori even be good for us?

understanding GI bleeding

Emergency and inpatient treatment of migraine: An American Headache Society

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Pharmacists improving care in care homes

PRACTICE BRIEF. Preventing Medication Errors in Home Care. Home Care Patients Are Vulnerable to Medication Errors

NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS

STRATTERA (Stra-TAIR-a)

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

Component 2: The Culture of Health Care

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

Safety Information Card for Xarelto Patients

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

TAKING CARE OF YOUR RHEUMATOID ARTHRITIS

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions

Medications for chronic pain

RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home

Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)

New Oral Anticoagulants. How safe are they outside the trials?

Review of Pharmacological Pain Management

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.

Awareness of the inappropriate use of GI prophylaxis and its cost. Adverse effects of proton pump inhibitor

NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide

National Patient Safety Goals Effective January 1, 2015

CHAPTER 21 Error in medical practice

Choosing Pain Medicine for Osteoarthritis. A Guide for Consumers

patient group direction

THE COMPARATIVE OUTCOME OF TOPICAL FORMULATIONS IN RHEUMATOID ARTHRITIS: A PROSPECTIVE STUDY IN 125 PATIENTS OF AGE GROUPS YEARS:

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

New Anticoagulants and GI bleeding

Transitioning a Pain Program Away From Chronic Opioid Prescribing

FAQs about Warfarin (brand name Coumadin )

Adrenaline autoinjector (EpiPen) for acute allergic anaphylaxis

National Patient Safety Goals Effective January 1, 2015

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

NIH INTERACT Evaluation. Welcome and Thank You to Project Participants

Paracetamol apollo Paracetamol apollo Paracetamol

Ask Your Doctor if There May Be a SMARTER CHOICE

Implementing an Evidence Based Hospital Discharge Process

Polymyalgia Rheumatica

New Oral Anticoagulants

Prescribing Framework for Donepezil in the Treatment and Management of Dementia

A Guide to Spine Injection Procedures

YALE UNIVERSITY SCHOOL OF MEDICINE: SECTION OF OTOLARYNGOLOGY PATIENT INFORMATION FUNCTIONAL ENDOSCOPIC SINUS SURGERY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Over-prescribing Excessive doses/duration of medicines Lacking indication. Mis-prescribing Unfavourable choice of medicine, dose, or duration

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

Understanding and Improving Medication Reconciliation Between Hospitals and Nursing Homes

Overview Medication Adherence Where Are We Today?

What s the Deal with NSAIDs?

criteria Dr. Cristín Ryan Queen s University Belfast c.ryan@qub.ac.uk

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

MEDICATION GUIDE. TRINTELLIX [trin -tel-ix] (vortioxetine) Tablets

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

NSAIDs and Peptic Ulcers

Rivaroxaban (Xarelto) for preventing blood clots after hip or knee replacement surgery

Warfarin Counseling. Clinic Patient Education

RED, BOOST, and You: Improving the Discharge Transition of Care

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

Essential Shared Care Agreement Drugs for Dementia

Rheumatology. Rheumatoid Arthritis

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

Cirrhosis and HCV. Jonathan Israel M.D.

The Importance of Using Insulin Safely. Learning Objectives

DVT/PE Management with Rivaroxaban (Xarelto)

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

Transcription:

Medication Errors in the Clinic: Adverse Drug Events: Can We Fill the Holes in the Swiss Cheese Model Fb February 15 th, 2011 Andy Steele

Harm Errors

Objectives: Things Learned 1. Lots of medication errors in clinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese 6. Cartoons, chants, and pictures can wake me up.

Case Report ME is a 52 year old male s/p CVA, with HTN, Depression, and Seizures Med List Aspirin 325 mg Every Day Crestor 5 mg Every Day Prozac 20 mg Every Day Docusate 0.4 mg tablets Every Day Metoprolol ER 50 mg Every Day Naproxen 500 mg Twice Daily Amolodipine10mgEvery mg Day Clonazepam 2 mg Am, 1 mg Noon, 2 mg PM

Errors Harm #1: Failure to address ASA/NSAID interaction

Case Report 10/08 Admitted with Hematemesis EGD: PUD, GUD Discharge Diagnosis: UGI Bleed EGD in 1 month, given date at discharge Do Not Take Aspirin or Naprosyn Until you talk to a Doctor Call if dizziness, dark bloody stools No mention of PCP FU

Case Report 10/08 Admitted with Hematemesis EGD: PUD, GUD Discharge Diagnosis: UGI Bleed EGD in 1 month, given date at discharge Do Not Take Aspirin or Naprosyn Until you talk to a Doctor Call if dizziness, dark bloody stools No mention of PCP FU

Errors Harm #2: Failure to Enter NSAIDs as a Side Effect or #2: Failure to Enter NSAIDs as a Side Effect or Contraindication

Case Report 11/08 Eye Clinic: no allergies 12/08 No Repeat EGD 4/09 Clonazepam refill visit, no mention of PUD Naprosyn on med list

Errors Harm #3 Failure to do Problem List Reconciliation

Case Report 5/09 No Show for EGD 2/2010 PUD noticed, doing well off Naprosyn

Errors Harm #4 Failure to Enter NSAIDs as a Side Effect or Contraindication

Case Report 5/10 Naprosyn refilled with 11 refills

Errors Harm #5 Failure to check past use of NSAID s

Case Report 6/2010 Admitted with hematemesis PUD, Gastric Ulcers, Transfused Naprosyn entered as a Contraindication with level of Severe Discharge Diagnosis: UGI Bleed FU PCP 1 2 weeks Do Not Take Aspirin Callif Chest pain,shortness of breath, other concerns

Case Report 9/20/2010 Refill requested for Naprosyn

Medication Errors in the Clinic: Adverse Drug Events: Can We Fill the Holes in the Swiss Cheese Model

Airline Crashes: 270 Die Friday, February 11 th, 2011

Airline Crashes: 270 Die Saturday, February 12 th, 2011

Airline Crashes: 270 Die Sunday, February 13 th, 2011

Airline Crashes: 270 Die Monday, February 14 th, 2011

Airline Crashes: 270 Die Tuesday, February 15 th, 2011

Burden of Medical Errors Published in 2000 98,000 deaths a year attributed to medical errors IOM (2000). To Err is Human: Building a Safer Health System

3,000,000 Annual Deaths 2,500,000 2,000,000 1,500,000 1,000,000 500,000 0

Nov 16, 2010

Figure 2. Rates of All Harms per 1000 Patient-Days, Identified by Internal Reviewers, According to Year. N Engl J Med 2010; 363:2124-2134 November 25, 2010

Definitions Adverse Drug Event (ADE) injury resulting from drug therapy Preventable Adverse Drug Event (pade) Known allergy and patient prescribed the medication Non preventable Adverse Drug Events New allergy to medication Adverse Drug Reaction (ADR) a response to a drug which is noxious and unintended and which occurs at doses normally used

ADE Is Not the Same as Medical Errors Adverse Drug Events (llbl (all blue) Medication cerrorsc Medical Errors Adverse Drug Reactions (dark blue only) 1. Nebeker JR, Barach P, Samore MH. Clarifying Adverse Drug Events: A Clinician s Guide to Terminology, Documentation, and Reporting. Ann Intern Med. 2004; 140:795-801.

pade in Ambulatory Care ADE: pade: 14.9 / 1,000 person months 5.6 / 1,000 person months ~25 35% ofade arepreventable 86.5% of pade s cardiovascular drugs, analgesics, and hypoglycemic agents pades requiring hospital admission 45% inadequate monitoring Failure to prescribe prophylaxis hl to patients taking nonsteroidal dlanti inflammatory drugs Lack of monitoring of diuretic, hypoglycemic, and anticoagulant Ann Pharmacother 2007; 41:1411-26.

NationalAmbulatoryMedical Care Survey 12% 1.2% Percentage visits with adverse effect of care 1.0% 0.8% 0.6% 0.4% 02% 0.2% 0.0% 2004 2006 2007

Burden of Ambulatory ADE s Over 4 million clinic or ED visits ~5% due to NSAID s Over 100,000 admissions annually Pharmacoepidemiology and Drug Safety, 2010; 19: 901 910

Thing Learned #1

Thing Learned #1 There are a butt load of errors in medicine

Thing Learned #1 Last year, I may have harmed nearly 1 patient out of 15 that I care for

1500 patients 1500*12= 18000 patient months 15*18 ADE 5*18pADE 90 pade/1500 patients = 10/150 p p p =1/15

Should NSAIDS s have been entered as an allergy? as a side effect? as a Contraindication?

Allergy hypersensitive disorder of the immune system Side Effect harmful and undesired effect judged to be secondary to a main or therapeutic effect

Contraindication Absolute there are no reasonable circumstances for giving gthe medication Relative patient t is at higher h risk ikof complications, but that these risks may be outweighed by other considerations

Do Alerts Help? 6 months in 2006 2,321 Clinicians 60,352 patients (1,833,254 prescriptions) 279,476 drug interaction alerts (~15%) NNI= 331 alerts to prevent 1 ADE 10% of alerts led to ~60% of averted ADE 10% alerts accepted ARCH INTERN MED/VOL 169 (NO. 16), SEP 14, 2009

Look Out For Too Many Alerts

Indicating Severity

Determining Severity

Rating Severity (modified from VA) MILD Requires minimal therapeutic intervention such as discontinuation of drug(s) MODERATE Requires active treatment of adverse reaction, or further testing or evaluation to assess extent of non serious outcome (see below for definition of serious). SEVERE Includes any serious outcome, resulting in lf life or organ threatening situation or death, significant or permanent disability, requiring intervention to prevent permanent impairment or damage, or requiring/prolonging hospitalization.

Rating Severity (modified from VA) MILD Requires minimal therapeutic intervention such as discontinuation of drug(s) MODERATE Requires active treatment of adverse reaction, or further testing or evaluation to assess extent of non serious outcome (see below for definition of serious). SEVERE Includes any serious outcome, resulting in lf life or organ threatening situation or death, significant or permanent disability, requiring intervention to prevent permanent impairment or damage, or requiring/prolonging hospitalization.

Thing Learned #2 It is important tto document and determine severity of allergies and side effects.

NSAID s and GI Issues Every 1 dollar spent on NSAIDs leads to $0.66 to$1.25 spent on GI side effects Arthritis Patients 1/3 of care costs for GI adverse events Aliment Pharmacol Ther 2010; 32: 1240 1248

NSAID s and GI Issues (25% PUD) Seminars in Arthritis and Rheumatism, Vol 32, No 3 (December, Suppl 1), 2002: pp 25-32

NSAID s and GI Issues 4 years ending in 2006 1380 sites, 46 countries 34,071 OA or RA patients Randomized to etoricoxib or diclofenac Tracked for GI complications Aliment Pharmacol Ther 2010; 32: 1240 1248

NSAID s and GI Issues 4 years ending in 2006 1380 sites, 46 countries 34,071 OA or RA patients Randomized to etoricoxib or diclofenac Tracked for GI complications Aliment Pharmacol Ther 2010; 32: 1240 1248

Burden of Ambulatory ADE s Over 4 million clinic or ED visits ~5% due to NSAID s Over 100,000 admissions annually Pharmacoepidemiology and Drug Safety, 2010; 19: 901 910

Significant predictors of clinical events and complicated events Aliment Pharmacol Ther 2010; 32: 1240 1248

Thing Learned #3 If I give NSAIDs to 100 of my patients, I expect 25 to get ulcers, and 1 2 will have a significant bleed.

Prevention of NSAID induced 970 references gastroduodenal d ulcers 23 misoprostol (PA) 9 standard dose H2RA 3 double dose H2RA 9 PPI Prevention of NSAID-induced gastroduodenal ulcers (Review) i Copyright 2010 The Cochrane Collaboration

Prevention of NSAID induced gastroduodenal ulcers Prevention of NSAID-induced gastroduodenal ulcers (Review) i Copyright 2010 The Cochrane Collaboration

Thing Learned #4 If I need to give NSAIDs to my patients, I will consider giving PPI s or double dose H2RA to prevent ulcers.

Harm Errors

Swiss Cheese Holes Propionibacter shermani bacteria Carbon dioxide released during fermentation Size of the holes change with acidity, temperature, and curing time Does the USA or Swiss want bigger holes?

Thing Learned #5 Bacterial lflatulence l make holes in Swiss cheese

Things Learned 1 2 3 4 5

Things Learned1 1. Lots of medication errors in clinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese

Things Learned 2 1. Lots of medication errors in clinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese

Things Learned 3 1. Lots of medication errors in clinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese

Things Learned 4 1. Lots of medication errors in clinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese

Things Learned 5 1. Lots of Errors 2. NSAID s cause bleeding ulcers 3. We should ldd document side id effects 4. We need to think about severity of allergies and side effects 5. Carbon Dioxide is important for Swiss Cheese 6. Tricks to wake me up

Things Learned 1. Lotsofmedicationerrors of errors inclinic 2. We should document medication side effects and severity 3. NSAID s cause ulcers, some bleed 4. We can reduce the chance of getting ulcers while on NSAID s 5. Carbon Dioxide is important for Swiss Cheese 6. Cartoons, chants, and pictures can wake me up.

Harm Errors

Plug The Holes ME is a 52 year old male s/p CVA, with HTN, Depression, and Seizures #1: Recognize e ASA/NSAID interaction: consider PPI or H2RA (Drug Drug Interaction with EBM Guidelines) #2: Enter NSAIDs as a Side Effect or Contraindication (Reports to check for Drug:Condition: Allergy match) #3 Reconcile Problem List (Comprehensive UpTo Date Problem List and Checklists) #4 Enter NSAIDs as a Side Effect or Contraindication #5 Failure check past use of NSAID s (More integrated electronic health record)

IT in Health Care

IT in Health Care

IT in Health Care

Harm Errors